跳至主要内容
临床试验/CTRI/2020/09/027525
CTRI/2020/09/027525尚未招募1 期

To study the potential role of Platelet Rich Plasma as a therapeutic modality in Melasma

Dr RPG Medical College Kangra0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age > 18 years
  • Non Pregnant and Non lactating women
  • Patients not taking oral contraceptives.
  • Patients with no history of chronic liver disease, thromboembolism, bleeding disorders, and abnormal coagulation profile; on antiplatelet, anticoagulant or systemic chemotherapy.
  • Patients with no history of hypertrophic scars or keloids, recurrent herpes infection or current cutaneous infection
  • Patients with no history psychological disorders
  • Patients who have not taken any other melasma therapy within last 3 months.

排除标准

  • Age less than 18 years
  • Pregnant and lactating women
  • Patients taking oral contraceptives
  • Patients with history of chronic liver disease, thromboembolism, bleeding disorders, and abnormal coagulation profile; on antiplatelet, anticoagulant or systemic chemotherapy
  • Patients with history of hypertrophic scars or keloids, recurrent herpes infection or current cutaneous infection
  • Patients with psychological disorders
  • Patients having unrealistic expectation from the treatment
  • Patients who have taken any other melasma therapy within last 3 months

研究者

发起方
Dr RPG Medical College Kangra

相似试验